Oct 28, 2022 / 02:00PM GMT
Operator
Good morning, ladies and gentlemen, and welcome to Hypera Pharma's conference call where we will discuss the results of the third quarter of 2022. We have with us Mr. Breno Oliveira, CEO; and Mr. Adalmario Couto, Executive Director of Investor Relations or IRO. We would like to inform you that this event is being recorded, and you may watch it on the company's Investor Relations website, hypera.com.br/ri. (Operator Instructions)
Before we continue, I would like to underscore that some of the information mentioned in this conference call may refer to projections or statements about the future. They are subject to risks, known and unknown, and uncertainties that can lead them to not come to pass or differ substantially from what was expected.
Now I would like to give the floor to Mr. Breno Oliveira, who will begin the presentation. Mr. Oliveira, over to you.
Breno Toledo Pires de Oliveira - Hypera S.A. - CEO & Director
Good morning, everyone, and welcome to our conference call for the earnings of the third quarter of 2022. I'll begin this
Q3 2022 Hypera SA Earnings Call Transcript
Oct 28, 2022
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers